NANCY EVANS: Open Payments
NPI 1245438670 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,746 in 58 payments from 20 companies in 2025. Trend: 2023 $213 · 2024 $778 · 2025 $1,746
Food & beverage: $1,746
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $380 |
| Amgen Inc. | 4 | $193 |
| Dexcom, Inc. | 3 | $179 |
| Novo Nordisk Inc | 8 | $166 |
| Abbott Laboratories | 3 | $147 |
| Lilly USA, LLC | 5 | $131 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Amneal Pharmaceuticals LLC | 3 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Ascendis Pharma Endocrinology Inc | 2 | $52 |
Products named: VRAYLAR, REPATHA, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, JARDIANCE, MOUNJARO, UNITHROID, Wegovy.
Industry payments across NY — which companies pay providers there.
